Harnessing living cells
CAR-T, TIL, NK-cell and other cellular approaches are advancing in selected indications and remain areas of active research.
Cancer science is evolving across cellular therapies, immunotherapy, molecular diagnostics, targeted medicines, artificial intelligence and new treatment platforms. ACO's ambition is to remain engaged with this progress while keeping evidence, safety and patient needs at the centre.
Emerging does not always mean proven, suitable or available. New approaches must be assessed for scientific rationale, clinical evidence, safety, regulatory status, manufacturing quality and relevance to the individual patient before they become part of a treatment discussion.
At American Center for Oncology, our goal is to combine clinical discipline, scientific curiosity and human compassion in every meaningful decision.
Explore the principles and capabilities that shape this part of the patient journey.
CAR-T, TIL, NK-cell and other cellular approaches are advancing in selected indications and remain areas of active research.
New combinations, biomarkers and immune-based strategies are being investigated across cancer types.
Molecular and other specialised tests may help identify clinically relevant features in selected patients.
Digital tools may assist workflows and analysis, but must be validated and used with professional oversight.
Research partnerships and well-designed studies help test whether promising ideas can improve outcomes.
Learn about ACO's approach to emerging therapies, research and responsible innovation.
Understand your diagnosis, questions, preferences and priorities.
Review relevant clinical information and identify what needs further evaluation.
Explain appropriate options, benefits, risks, alternatives and uncertainties.
Agree on a plan with you and coordinate the next steps with your care team.
Learn about ACO's approach to emerging therapies, research and responsible innovation. Our team can help you understand the next appropriate step.
Connect with our team →Replace the sample email address with ACO's verified contact details before publishing.